T. Rowe Price Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.3M | Buy |
|
|||||
|
2025
Q1 | $62.3M | Sell |
|
|||||
|
2024
Q4 | $244M | Sell |
|
|||||
|
2024
Q3 | $234M | Sell |
|
|||||
|
2024
Q2 | $678M | Buy |
|
|||||
|
2024
Q1 | $623M | Buy |
|
|||||
|
2023
Q4 | $315M | Buy |
|
|||||
|
2023
Q3 | $227M | Buy |
|
|||||
|
2023
Q2 | $76.7M | Sell |
|
|||||
|
2023
Q1 | $68.8M | Buy |
|
|||||
|
2022
Q4 | $60.5M | Buy |
|
|||||
|
2022
Q3 | $66.6M | Sell |
|
|||||
|
2022
Q2 | $76.7M | Sell |
|
|||||
|
2022
Q1 | $105M | Sell |
|
|||||
|
2021
Q4 | $122M | Sell |
|
|||||
|
2021
Q3 | $110M | Sell |
|
|||||
|
2021
Q2 | $103M | Sell |
|
|||||
|
2021
Q1 | $83.8M | Sell |
|
|||||
|
2020
Q4 | $98.5M | Sell |
|
|||||
|
2020
Q3 | $96.4M | Buy |
|
|||||
|
2020
Q2 | $81.7M | Sell |
|
|||||
|
2020
Q1 | $80.3M | Buy |
|
|||||
|
2019
Q4 | $91.1M | Sell |
|
|||||
|
2019
Q3 | $87.2M | Buy |
|
|||||
|
2019
Q2 | $71.8M | Sell |
|
|||||
|
2019
Q1 | $74.4M | Buy |
|
|||||
|
2018
Q4 | $56.1M | Buy |
|
|||||
|
2018
Q3 | $62.8M | Sell |
|
|||||
|
2018
Q2 | $53.9M | Buy |
|
|||||
|
2018
Q1 | $51.5M | Buy |
|
|||||
|
2017
Q4 | $41.4M | Sell |
|
|||||
|
2017
Q3 | $40.4M | Sell |
|
|||||
|
2017
Q2 | $46.4M | Sell |
|
|||||
|
2017
Q1 | $38.3M | Sell |
|
|||||
|
2016
Q4 | $38.5M | Buy |
|
|||||
|
2016
Q3 | $47.9M | Sell |
|
|||||
|
2016
Q2 | $61.8M | Buy |
|
|||||
|
2016
Q1 | $53.6M | Sell |
|
|||||
|
2015
Q4 | $48.1M | Sell |
|
|||||
|
2015
Q3 | $43.4M | Sell |
|
|||||
|
2015
Q2 | $43.5M | Buy |
|
|||||
|
2015
Q1 | $43.2M | Buy |
|
|||||
|
2014
Q4 | $37.2M | Buy |
|
|||||
|
2014
Q3 | $29.2M | Buy |
|
|||||
|
2014
Q2 | $24.4M | Sell |
|
|||||
|
2014
Q1 | $21.7M | Sell |
|
|||||
|
2013
Q4 | $23.1M | Sell |
|
|||||
|
2013
Q3 | $30.2M | Sell |
|
|||||
|
2013
Q2 | $537M | Buy |
|